SEC Form 4 · accession 0001209191-16-106797
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vic C. Knauf
Officer — Chief Scientific Officer · Director
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 9:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2016 | M | 300 | $1.08 | A | 47,434 | D | |
| Common Stock | Mar 3, 2016 | S | 300 | $2.97 | D | 47,134 | D | |
| Common Stock | Mar 4, 2016 | M | 2,973 | $1.08 | A | 50,107 | D | |
| Common Stock | Mar 4, 2016 | S | 2,973 | $3.224 | D | 47,134 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.08 | Mar 3, 2016 | M | 300 | D | — | Jun 30, 2018 | Common Stock | 300 | 235,534 | D |
| Employee Stock Option (right to buy)F2 | $1.08 | Mar 4, 2016 | M | 2,973 | D | — | Jun 30, 2018 | Common Stock | 2,973 | 232,561 | D |
Explanation of responses
- F1The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective February 1, 2016.
- F2The option is fully exercisable as of the date hereof.